Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
Status:
Withdrawn
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The increased risk for contrast-induced nephropathy (CIN) in patients with chronic kidney
disease (CKD) undergoing coronary angiography (CAG) has been established. Current and
historical data on CIN prevention strategies have shown wide variation with respect to the
optimal type, route and timing of these therapies. We investigate the role for oral hydration
and/or oral sodium bicarbonate administration compared to intravenous hydration and/or sodium
bicarbonate in patients with CKD undergoing CAG.